nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Active immunotherapy of multiple myeloma
|
Houet, Leonora |
|
2006 |
42 |
11 |
p. 1653-1660 8 p. |
artikel |
2 |
Allogeneic haematopoietic cell transplantation for multiple myeloma: Reducing transplant-related mortality while harnessing the graft-versus-myeloma effect
|
Zeiser, Robert |
|
2006 |
42 |
11 |
p. 1601-1611 11 p. |
artikel |
3 |
Angiogenesis in multiple myeloma
|
Jakob, Christian |
|
2006 |
42 |
11 |
p. 1581-1590 10 p. |
artikel |
4 |
An update: Health economics of managing multiple myeloma
|
Moeremans, K. |
|
2006 |
42 |
11 |
p. 1684-1691 8 p. |
artikel |
5 |
Bone markers in multiple myeloma
|
Heider, Ulrike |
|
2006 |
42 |
11 |
p. 1544-1553 10 p. |
artikel |
6 |
Conventional diagnostics in multiple myeloma
|
San Miguel, Jesús F. |
|
2006 |
42 |
11 |
p. 1510-1519 10 p. |
artikel |
7 |
Cytogenetics and molecular cytogenetics in multiple myeloma
|
Liebisch, Peter |
|
2006 |
42 |
11 |
p. 1520-1529 10 p. |
artikel |
8 |
Editorial board
|
|
|
2006 |
42 |
11 |
p. ii- 1 p. |
artikel |
9 |
Epidemiology and outcomes research for MGUS, myeloma and amyloidosis
|
Sirohi, Bhawna |
|
2006 |
42 |
11 |
p. 1671-1683 13 p. |
artikel |
10 |
Familial risks and temporal incidence trends of multiple myeloma
|
Altieri, Andrea |
|
2006 |
42 |
11 |
p. 1661-1670 10 p. |
artikel |
11 |
Genetics and molecular profiling of multiple myeloma: Novel tools for clinical management?
|
Tassone, Pierfrancesco |
|
2006 |
42 |
11 |
p. 1530-1538 9 p. |
artikel |
12 |
Multiple myeloma: Monoclonal antibodies-based immunotherapeutic strategies and targeted radiotherapy
|
Chatterjee, Malay |
|
2006 |
42 |
11 |
p. 1640-1652 13 p. |
artikel |
13 |
Myeloma bone disease and treatment options
|
Yeh, Howard S. |
|
2006 |
42 |
11 |
p. 1554-1563 10 p. |
artikel |
14 |
Proteasome inhibition in multiple myeloma
|
Kropff, Martin |
|
2006 |
42 |
11 |
p. 1623-1639 17 p. |
artikel |
15 |
Signalling and survival pathways in multiple myeloma
|
Bommert, Kurt |
|
2006 |
42 |
11 |
p. 1574-1580 7 p. |
artikel |
16 |
State of the art therapy in multiple myeloma and future perspectives
|
Denz, Ulrich |
|
2006 |
42 |
11 |
p. 1591-1600 10 p. |
artikel |
17 |
Thalidomide and lenalidomide in the treatment of multiple myeloma
|
Kumar, Shaji |
|
2006 |
42 |
11 |
p. 1612-1622 11 p. |
artikel |
18 |
The role of anatomic and functional staging in myeloma: Description of Durie/Salmon plus staging system
|
Durie, Brian G.M. |
|
2006 |
42 |
11 |
p. 1539-1543 5 p. |
artikel |
19 |
The role of the bone microenvironment in the pathophysiology and therapeutic management of multiple myeloma: Interplay of growth factors, their receptors and stromal interactions
|
Mitsiades, Constantine S. |
|
2006 |
42 |
11 |
p. 1564-1573 10 p. |
artikel |
20 |
160 years of multiple myeloma: Progress and challenges
|
Engelhardt, Monika |
|
2006 |
42 |
11 |
p. 1507-1509 3 p. |
artikel |